Vaccine Biotherapy Of Cancer: Autologous Tumor Cells and Dendritic Cells as Active Specific Immunotherapy in Patients With Metastatic Melanoma
Phase of Trial: Phase II
Latest Information Update: 27 Jul 2016
At a glance
- Drugs Eltrapuldencel-T (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- Acronyms DCVaccineMel
- 07 Jun 2016 5-year follow-up results from NCT00948480 and NCT00436930 trials (n=72) presented at the 52nd Annual Meeting of the American Society of Clinical Oncology
- 28 Jul 2009 Results have been published in the June 2009 issue of Cancer Biotherapy and Radiopharmaceuticals, according to a Hoag Memorial Hospital Presbyterian media release.
- 01 Nov 2005 New trial record.